Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes
- PMID: 1500196
- PMCID: PMC257405
- DOI: 10.1128/iai.60.9.3897-3903.1992
Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes
Erratum in
- Infect Immun 1992 Dec;60(12):5324
Abstract
To obtain nontoxic and highly immunogenic lipopolysaccharide (LPS) for immunization, we incorporated Neisseria meningitidis LPS into liposomes. Native LPS and its salts were incorporated by the method of dehydration-rehydration of vesicles or prolonged cosonication. The most complete incorporation of LPS into liposomes and a decrease in toxicity were achieved by the method of dehydration-rehydration of vesicles. Three forms of LPS (H+ form, Mg2+ salt, and triethanolamine salt) showed different solubilities in water, the acidic form of LPS, with the most pronounced hydrophobic properties, being capable of practically complete association with liposomal membranes. An evaluation of the activity of liposomal LPS in vitro (by the Limulus amoebocyte test) and in vivo (by monitoring the pyrogenic reaction in rabbits) revealed a decrease in endotoxin activity of up to 1,000-fold. In addition, the pyrogenic activity of liposomal LPS was comparable to that of a meningococcal polysaccharide vaccine. Liposomes had a pronounced adjuvant effect on the immune response to LPS. Thus, the level of anti-LPS plaque-forming cells in the spleens of mice immunized with liposomal LPS was 1 order of magnitude higher and could be observed for a longer time (until day 21, i.e., the term of observation) than in mice immunized with free LPS. The same regularity was revealed in a study done with an enzyme-linked immunosorbent assay. This study also established that antibodies induced by immunization belonged to the immunoglobulin M and G classes, which are capable of prolonged circulation. Moreover, liposomal LPS induced a pronounced immune response in CBA/N mice (defective in B lymphocytes of the LyB-5+ subpopulation). The latter results indicate that the immunogenic action of liposomal LPS occurs at an early age.
Similar articles
-
Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.Clin Vaccine Immunol. 2010 Apr;17(4):487-95. doi: 10.1128/CVI.00423-09. Epub 2010 Jan 27. Clin Vaccine Immunol. 2010. PMID: 20107001 Free PMC article.
-
Non-specific modulation of the immune response with liposomal meningococcal lipopolysaccharide: role of different cells and cytokines.Vaccine. 1994 Sep;12(12):1064-70. doi: 10.1016/0264-410x(94)90174-0. Vaccine. 1994. PMID: 7998414
-
[The immunological activity of Neisseria meningitidis lipo-oligosaccharide incorporated into liposomes].Zh Mikrobiol Epidemiol Immunobiol. 1995 Jan-Feb;(1):49-53. Zh Mikrobiol Epidemiol Immunobiol. 1995. PMID: 7778375 Russian.
-
Neisseria meningitidis lipopolysaccharides in human pathology.J Endotoxin Res. 2001;7(6):401-20. J Endotoxin Res. 2001. PMID: 11753210 Review.
-
[Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].Ugeskr Laeger. 2008 Feb 4;170(6):421-6. Ugeskr Laeger. 2008. PMID: 18252172 Review. Danish.
Cited by
-
Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.Clin Vaccine Immunol. 2012 May;19(5):711-22. doi: 10.1128/CVI.05683-11. Epub 2012 Mar 21. Clin Vaccine Immunol. 2012. PMID: 22441387 Free PMC article.
-
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.Vaccine. 2009 May 18;27(23):3013-21. doi: 10.1016/j.vaccine.2009.03.034. Epub 2009 Apr 3. Vaccine. 2009. PMID: 19428913 Free PMC article.
-
Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.Clin Vaccine Immunol. 2010 Apr;17(4):487-95. doi: 10.1128/CVI.00423-09. Epub 2010 Jan 27. Clin Vaccine Immunol. 2010. PMID: 20107001 Free PMC article.
-
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.Trends Biotechnol. 2011 Jun;29(6):294-306. doi: 10.1016/j.tibtech.2011.02.004. Epub 2011 Apr 2. Trends Biotechnol. 2011. PMID: 21459467 Free PMC article. Review.
-
Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.Infect Immun. 2000 Nov;68(11):6202-8. doi: 10.1128/IAI.68.11.6202-6208.2000. Infect Immun. 2000. PMID: 11035726 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources